PCWHF HRT provision during COVID-19 guidance
This summary is intended to aid primary healthcare practitioners in initiating, reviewing, and prescribing hormone replacement therapy for women during COVID-19.
NICE antenatal care guideline
A brief summary of NICE guidance on routine care for the healthy pregnant woman. Includes information, lifestyle advice, and foetal and maternal screening.
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.
FSRH UKMEC contraception guideline
A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.
FSRH intrauterine contraception guideline
This concise summary of guidance on intrauterine contraception (IUC) includes efficacy, insertion, duration of use, risks, benefits, and complications.
NICE LARC guideline
This guideline covers important points to raise with women that may benefit from long-acting reversible contraception
NICE recommendations for women with pelvic organ prolapse
Summary includes recommendations on non-surgical management of prolapse, and assessment and management of complications associated with mesh surgery.
Urinary incontinence and pelvic organ prolapse in women: management
Summary of NICE guidance covers history taking, assessing urinary incontinence, investigations, non-surgical management, and indicators for referral.
SIGN FASD guideline
Failure to recognise prenatal alcohol exposure as a possible cause of behavioural difficulties may contribute to adverse outcomes for the child.
PHE vaccination in pregnancy guideline
This concise and useful summary of PHE guidance covers PHE monitoring of women vaccinated in pregnancy or shortly before conception.
Educational resources
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Information intended for healthcare professionals only.
Uncomplicated recurrent UTI guideline
This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from a pharmaceutical company.